Presentation is loading. Please wait.

Presentation is loading. Please wait.

Northwestern University Feinberg School of Medicine New Trends in organ donation and Transplantation Juan Carlos Caicedo, MD FACS Director, Hispanic Transplant.

Published byDulcie Fleming Modified over 9 years ago

Similar presentations

Presentation on theme: "Northwestern University Feinberg School of Medicine New Trends in organ donation and Transplantation Juan Carlos Caicedo, MD FACS Director, Hispanic Transplant."— Presentation transcript:

1 Northwestern University Feinberg School of Medicine New Trends in organ donation and Transplantation Juan Carlos Caicedo, MD FACS Director, Hispanic Transplant Program Adult transplant Surgeon (NMH) Pediatric Transplant Surgeon (LCH)

2 Overview Introduction Kidney ( Living / deceased/ combined stem cell) Liver: whole, split, reduce size, living donor 2

3 Who Needs a Transplant? Transplantation is offered to patients who: are in end-stage organ failure have no other surgical or medical option available to them have a limited life expectancy without a transplant have undergone a rigorous and thorough assessment process and meet all necessary criteria

4 4 Type of donors Deceased (dead) donors -Brain dead donors: intact heartbeat & circulation, on ventilator less than 3% of all deaths -Donors after cardiac death: occurs in hopeless cases in the hospital where the decision to withdraw life-support is made (decision is independent of the decision to donate). Organ donation occurs immediately once the heart has stopped and the patient is declared dead Living donor -Patient chooses to donate one or part of an organ to someone on a transplant waiting list can only occur with organs when removal will NOT cause grave harm to the donor-

5 Northwestern University Feinberg School of Medicine United States Organ Transplantation OPTN & SRTR Annual Data Report, 2011

6 Patients on the waiting list on December 31 of the year (active listings only)

7 Transplants performed during the year (adult & pediatric combined)

8 First-year all-cause graft survival

9 Northwestern University Feinberg School of Medicine Adult Kidney Transplantation

10 End Stage Renal Disease Dimension of the problem >500.000 people in US Options: Dialysis and kidney transplantation US kidney waiting list: 105.124 people / 2013

11 Kidney Failure: Treatment Kidney Transplantation “ Best option” -Replace all functions of the kidney -Increase survival and quality of life -Decrease complications -Cost effective

12 Incident ESRD Rate and Transplant Rate 12 USRDS 2010 ADR

13 Northwestern University Feinberg School of Medicine 2013: 105124 Waiting list 2012: 16485 Transplanted 758 ( 4.5%) Pediatric pts Whites :38% AA: 34% Hispanics: 19% Asian: 8%

14 Distribution of adult patients waiting for a kidney transplant

15 Deceased donor kidney donation rates

16 Cause of death among deceased kidney donors

17 Organs recovered per donor (ORPD), by SCD, DCD, & ECD status

18 Delayed graft function among adult kidney transplant recipients

19 Kidney donations from living donors

20 Living kidney donation Laparoscopic vs Open - Safe - Less pain - Fast recovery - POD 1: Home - Smaller Incisions

21 Intended kidney transplant procedure type, & percent of intended laparoscopic procedures converted to open

22 Number of transplants from living donors, by donor relation All patients receiving a living donor kidney transplant. USRDS 2010 ADR

23 Kidney Transplantation

24

25 Sensitized Patients Sensitized Very Highly Sensitized36% Sensitized Total = 17,814 pts 2010: 25% Sensitized

26 Options for Sensitized and ABO incompatible Patients Wait and hope Desensitization Live Donor Deceased Donor Live Donor Paired Exchange List Exchange Wait and hope Desensitization Live Donor Deceased Donor Live Donor Paired Exchange List Exchange

27 Paired kidney donations

28 Basic Kidney Paired Donation (KPD)

29 Northwestern University Feinberg School of Medicine

30 Desensitization 30 N Engl J Med 365;4 July 28, 2011

31 Trends in Transplant Medications 31

32 Immunosuppression use in adult kidney transplant recipients

33 Initial immunosuppression regimen in adult kidney transplant recipients, 2011

34 Acute rejections within the first year post-transplant 34 First-time, kidney-only transplant recipients, age 18 & older, with functioning graft at discharge. Source: USRDS 2010 ADR

35 Trends in Transplant Research 35

36 The co-existence of two genetically different components in one organism Chimerism induces tolerance Mixed Chimeras How can we make it safe?

37 Northwestern Clinical Tolerance Protocols Sequential kidney/HSC in HLA matched related Simultaneous kidney/HSC in HLA mismatched 37

38 HLA-Matched Protocol Current Enrollment – 20/20 First patient enrolled January 2008 HLA identical siblings Excluded if high risk of recurrent disease in the allograft (role of immunosuppression in preventing disease recurrence) 38 PI: Joshua Miller

39 39 HSCT mobilized, collected, processed, & cryopreserved (> 2 wks before Tx) Conditioning Fludarabine, cytoxan, 200 cGy TBI Perform Transplant Processed donor leukopheresis product/marrow enriched for HSC, FC and progenitors (FCRx) Simultaneous FCRx +Kidney Transplant d0d +1

40 Adult kidney transplants

41 Outcomes among adult kidney transplant recipients: deceased donor

42 Outcomes among adult kidney transplant recipients: living donor

43 Half-lives for adult kidney transplant recipients

44 Liver Transplantation Type of donor: Living vs deceased donor Type of graft: Partial vs whole organ

45 Whole Organ Orthotopic Liver Transplant Standard technique. This figure illustrates a completed liver transplant with vascular and biliary anastomoses.

46 Partial Grafts / Liver transplantation (LTX) -Reduce Size Ltx -Split LTx -Living Donor Ltx

47 Partial Liver Transplantation The split through midplane with right and left lobe grafts Reference: Humar A, et al. Amer J Transpl 2001;1:366-72 Schematic drawing of the right lobe after transplantation into the recipient. The major vascular anastomosis and drainage of the bile duct into a Roux loop of bowel is illustrated

48 Northwestern University Feinberg School of Medicine Adult Liver Transplantation 48

49

50

51 Distribution of adult patients waiting for a liver transplant

52 Liver donors who are DCD

53 Liver transplants from living donors, by donor relation

54 Living donor liver transplant graft type

55 Total adult liver transplants

56 Adult liver transplants

57 Graft failure among adult liver transplant recipients: deceased donor

58 Immunosuppression use in adult liver transplant recipients

59 59 Conclusion Transplantation offers a second chance at life to thousands of people. It has been proven over and over again to be very successful. However, transplantation can only occur if someone consents to the ultimate gift – organ and tissue donation. liver transplant recipient Kidney donor and recipient

60 Northwestern University Feinberg School of Medicine Thank you 60

Download ppt "Northwestern University Feinberg School of Medicine New Trends in organ donation and Transplantation Juan Carlos Caicedo, MD FACS Director, Hispanic Transplant."

Similar presentations

The Donor Most organ donors are accident victims that have suffered severe and eventually fatal injuries-often a severe head injury. Death is pronounced.

The Donor Most organ donors are accident victims that have suffered severe and eventually fatal injuries-often a severe head injury. Death is pronounced.
Ken Andreoni, MD Chair UNOS Kidney Comm The Ohio State University

Ken Andreoni, MD Chair UNOS Kidney Comm The Ohio State University
Hematopoietic Stem Cell Transplantation Lynn Savoie September 30, 2006.

Hematopoietic Stem Cell Transplantation Lynn Savoie September 30, 2006.
Cells, tissues and organs All living organisms are made up of cells. Large numbers of cells group together to form tissue. Tissues can combine to form.

Cells, tissues and organs All living organisms are made up of cells. Large numbers of cells group together to form tissue. Tissues can combine to form.
Basics of Organ Transplantation Lon Eskind, MD Director Liver Transplant, CMC Assoc. Medical Director of LifeShare.

Basics of Organ Transplantation Lon Eskind, MD Director Liver Transplant, CMC Assoc. Medical Director of LifeShare.
You have the power to Donate Life!. 20 people Every day nearly 20 people will die waiting for a life-saving organ transplant. The national waiting list.

You have the power to Donate Life!. 20 people Every day nearly 20 people will die waiting for a life-saving organ transplant. The national waiting list.
Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index American Journal of Transplantation 2006; 6: 783–790 S. Fenga, N.P.

Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index American Journal of Transplantation 2006; 6: 783–790 S. Fenga, N.P.
What makes a pancreas allograft marginal? Peter J Friend University of Oxford.

What makes a pancreas allograft marginal? Peter J Friend University of Oxford.
Donor Utilization: Making Use of a Precious Resource in Cardiac Transplant Jason W. Smith, MD Assistant Professor of Surgery The University of Washington.

Donor Utilization: Making Use of a Precious Resource in Cardiac Transplant Jason W. Smith, MD Assistant Professor of Surgery The University of Washington.
USRDS Clinical Indicators of Renal Allograft Loss Lawrence Y.C. Agodoa, MD FACP Jon J. Snyder, MS Bertram L. Kasiske, MD Allan J. Collins, MD FACP United.

USRDS Clinical Indicators of Renal Allograft Loss Lawrence Y.C. Agodoa, MD FACP Jon J. Snyder, MS Bertram L. Kasiske, MD Allan J. Collins, MD FACP United.
Lung Transplantation: What? Who? When? Marshall I. Hertz, MD University of Minnesota Medical School and Fairview-University Medical Center Medical Director,

Lung Transplantation: What? Who? When? Marshall I. Hertz, MD University of Minnesota Medical School and Fairview-University Medical Center Medical Director,
9.PCH.1.2 Summarize the procedures for organ donation, local and state resources, and benefits.

9.PCH.1.2 Summarize the procedures for organ donation, local and state resources, and benefits.
TRANSPLANTATION TODAY LILLY BARBA, M.D. MEDICAL DIRECTOR RENAL TRANSPLANT PROGRAM HARBOR-UCLA MEDICAL CENTER APRIL 12, 2010.

TRANSPLANTATION TODAY LILLY BARBA, M.D. MEDICAL DIRECTOR RENAL TRANSPLANT PROGRAM HARBOR-UCLA MEDICAL CENTER APRIL 12, 2010.
Author(s): Silas P. Norman, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Noncommercial–Share.

Author(s): Silas P. Norman, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Noncommercial–Share.
Living Donor Kidney Transplant. What does the evidence say about outcome ? Professor Peter J Conlon.

Living Donor Kidney Transplant. What does the evidence say about outcome ? Professor Peter J Conlon.
Early Outcomes of Transplant Recipients in the OPTN Kidney Paired Donation Pilot Program Mark Aeder, MD, University Hospitals Case Med Center Darren Stewart,

Early Outcomes of Transplant Recipients in the OPTN Kidney Paired Donation Pilot Program Mark Aeder, MD, University Hospitals Case Med Center Darren Stewart,
ORGAN DONATION By: Aubree Malone. “When you’re not an organ donor when you die, you’re taking a lot of people with you.”

ORGAN DONATION By: Aubree Malone. “When you’re not an organ donor when you die, you’re taking a lot of people with you.”
Australian States 2004 - 2009 Number of Donors Per Million Population Aust 11 10 10 9 12 11 * NSW population excludes residents of the NSW Southern Area.

Australian States Number of Donors Per Million Population Aust * NSW population excludes residents of the NSW Southern Area.
© ANZOD Registry Australian States 2003 - 2008 Number of Donors Per Million Population Aust 9 11 10 10 9 12 * NSW population excludes residents of the.

© ANZOD Registry Australian States Number of Donors Per Million Population Aust * NSW population excludes residents of the.
A Mission to Save More Lives Where we’ve been, where we are, and where we need to be Thomas A. Nakagawa, M.D, FAAP, FCCM Professor, Anesthesiology and.

A Mission to Save More Lives Where we’ve been, where we are, and where we need to be Thomas A. Nakagawa, M.D, FAAP, FCCM Professor, Anesthesiology and.

Similar presentations

Ads by Google